Certain lots of the injectable drug Cubicin (daptomycin), used to treat skin infections and certain blood stream infections, are being recalled because of the potential presence of glass particles in vials. The administration of glass particulate, if present in an intravenous drug, poses a potential safety risk to patients such as thromboemobolism or a life-threatening pulmonary emboli. Other adverse events that could result from administration of glass particulate include phlebitis, mechanical block of the capillaries or arteries, activation of platelets, or subsequent generation of microthrombi. It can also cause the formation of granulomas, which can result in a protective local ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.